Plain-English translation of NCT07567196 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a special type of imaging scan called PET can help surgeons better identify and remove aggressive brain tumors (glioblastomas and other high-grade gliomas). Currently, doctors rely mainly on MRI scans to guide surgery, but cancer cells often spread beyond what MRI can see. This study checks whether PET imaging, which uses a tracer substance to light up tumor cells, helps surgeons remove more of the cancer while keeping patients safe.
Aggressive brain tumors are very difficult to treat, and survival is often short—around 15 months even with current best care. Removing as much of the tumor as possible during surgery is one of the few things doctors can control to improve outcomes. This trial exists to see if the new imaging approach helps surgeons achieve more complete removal and ultimately helps patients live longer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive brain surgery with the help of the special PET imaging scan to guide the surgeon's work. The researchers will track how much of your tumor is removed and monitor your health afterward to see how long you survive and how well you're doing. The study involves about 100 patients across multiple medical centers and will help doctors understand whether this new imaging approach truly improves outcomes for people with aggressive brain tumors.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
Italy